Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» July 2011
July 2011
Oncothyreon: Analyzing Trial Data and Concluding Likely Success
Oncothyreon: Analyzing Trial Data and Concluding Likely Success
Seeking Alpha
Oncothyreon
Stimuvax
vaccines
cancer
Merck plans more job cuts; 2Q profit rises
Merck plans more job cuts; 2Q profit rises
Yahoo/AP
Merck
earnings
layoffs
Kindler Undone: The Dysfunctional Pfizer Culture
Kindler Undone: The Dysfunctional Pfizer Culture
Pharmalot
Pfizer
corporate culture
Jeff Kindler
Pozen takes 2nd-quarter loss as payments related to new arthritis drug Vimovo decline
Pozen takes 2nd-quarter loss as payments related to new arthritis drug Vimovo decline
Yahoo/AP
arthritis
vivmo
earnings
Pozen
Why Medicis Pharmaceutical May Be About to Take Off
Why Medicis Pharmaceutical May Be About to Take Off
Motley Fool
Medicis
Medicis Pharmaceutical Earnings Preview
Medicis Pharmaceutical Earnings Preview
Motley Fool
earnings
Medicis
Pfizer’s Prempro Didn’t Cause Woman’s Cancer, Jury Concludes
Pfizer’s Prempro Didn’t Cause Woman’s Cancer, Jury Concludes
Bloomberg
Pfizer
Prempro
Wyeth
Pfizer Offer for Remaining Shares Not Enough, Icagen Holders Say
Pfizer Offer for Remaining Shares Not Enough, Icagen Holders Say
Bloomberg
Icagen
Pfizer
M&A
Pfizer: Dividend Dynamo or Blowup?
Pfizer: Dividend Dynamo or Blowup?
Motley Fool
dividends
Pfizer
Bristol-Myers Squibb: New Product Potential Outstanding, But Patent Cliff Looms
Bristol-Myers Squibb: New Product Potential Outstanding, But Patent Cliff Looms
Seeking Alpha
pipelines
earnings
Bristol-Myers Squibb
patents
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »